Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanyi Meng

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|July 24, 2012
[Long-term outcomes of nilotinib treatment for chronic myelogenous leukemia patients with imatinib resistance or intolerance]Yongqiang Wei, Xian Zhang, Weiwei Chen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 5, 2015
Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic MalignanciesQingshan Li, Fanyi Meng, Ming Zhou, et al.
Molecular Immunology|March 6, 2018
Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patientsYong Mao, Cheng Wang, Fanyi Meng, et al.
Nature Structural & Molecular Biology|January 9, 2023
Structural mechanisms of calmodulin activation of Shigella effector OspC3 to ADP-riboxanate caspase-4/11 and block pyroptosisYanjie Hou, Huan Zeng, Zilin Li, et al.
Journal of Hematology & Oncology|June 14, 2023
Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cellsFanyi Meng, Siqi Zhang, Juan Xie, et al.
Polymers|October 16, 2025
Mechanisms Underpinning Dynamic Impact Resistance Reinforcement by Multi-Scale Synergistic Effect Through Nano-Silica and Carbon Hollow MicrosphereYingying Yu, Cheng Yang, Yaxi Zhang, et al.
Science (New York, N.Y.)|April 25, 2024
Cleavage-independent activation of ancient eukaryotic gasdermins and structural mechanismsYueyue Li, Yanjie Hou, Qi Sun, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 18, 2016
Berberine acts as a putative epigenetic modulator by affecting the histone codeZhixiang Wang, Yuan Liu, Yong Xue, et al.
Stem Cell Reviews and Reports|April 11, 2025
Chidamide, Rituximab Plus EAC Regimen with Autologous Hemopoietic Stem Cell Transplantation in High-risk and Relapsed/Refractory B-cell Lymphoma and Long Term Follow-upShunhua Huang, Fanyi Meng, Xiaoguo Wang, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in chinaKefeng Shen, Qifa Liu, Jing Sun, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|July 24, 2012
[Long-term outcomes of nilotinib treatment for chronic myelogenous leukemia patients with imatinib resistance or intolerance]Yongqiang Wei, Xian Zhang, Weiwei Chen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 5, 2015
Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic MalignanciesQingshan Li, Fanyi Meng, Ming Zhou, et al.
Molecular Immunology|March 6, 2018
Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patientsYong Mao, Cheng Wang, Fanyi Meng, et al.
Nature Structural & Molecular Biology|January 9, 2023
Structural mechanisms of calmodulin activation of Shigella effector OspC3 to ADP-riboxanate caspase-4/11 and block pyroptosisYanjie Hou, Huan Zeng, Zilin Li, et al.
Journal of Hematology & Oncology|June 14, 2023
Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cellsFanyi Meng, Siqi Zhang, Juan Xie, et al.
Polymers|October 16, 2025
Mechanisms Underpinning Dynamic Impact Resistance Reinforcement by Multi-Scale Synergistic Effect Through Nano-Silica and Carbon Hollow MicrosphereYingying Yu, Cheng Yang, Yaxi Zhang, et al.
Science (New York, N.Y.)|April 25, 2024
Cleavage-independent activation of ancient eukaryotic gasdermins and structural mechanismsYueyue Li, Yanjie Hou, Qi Sun, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 18, 2016
Berberine acts as a putative epigenetic modulator by affecting the histone codeZhixiang Wang, Yuan Liu, Yong Xue, et al.
Stem Cell Reviews and Reports|April 11, 2025
Chidamide, Rituximab Plus EAC Regimen with Autologous Hemopoietic Stem Cell Transplantation in High-risk and Relapsed/Refractory B-cell Lymphoma and Long Term Follow-upShunhua Huang, Fanyi Meng, Xiaoguo Wang, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in chinaKefeng Shen, Qifa Liu, Jing Sun, et al.
Pageof 12